PTK2 and hepatoblastoma: Moreover, Gillory et al. [54] demonstrated that the inhibition of FAK phosphorylation/activation by silencing or by specific drug delivery caused a reduction of cell viability, invasion and migration of human hepatoblastoma HuH6 cells.